Single-Cell Screening Platform Development

About Flexomics

Flexomics is an early-stage biotech innovator building a unique functional genomics platform. Its core technology, centered on the FLEX picowell chip, enables researchers to culture, assay, and image live cells before performing single-cell RNA sequencing on the same sample, creating a direct link between cell behavior and molecular identity. The company, founded in 2020, operates as a private platform technology provider, securing non-dilutive funding through prestigious grants and industry partnerships to advance its tools for therapeutic discovery.

Therapeutic Areas

Other Platform Technology Drugs